Understanding how sex differences affect inflammation in gum disease

Inflammasome regulation underlying sexual dimorphism in periodontitis

NIH-funded research Univ of North Carolina Chapel Hill · NIH-11009953

This study is looking at how certain proteins that cause inflammation might affect gum disease differently in men and women, especially for those with severe cases that lead to tooth loss, to help find better treatments for people who don’t get better with regular care.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill NIH-funded
Lab location1 site (Chapel Hill, United States)
Project IDNIH-11009953 on NIH RePORTER

What this research studies

This research investigates the role of inflammasomes, which are protein complexes involved in inflammation, in the development of periodontitis, a common gum disease that affects bone and tissue supporting teeth. The study aims to explore how these inflammasomes function differently in males and females, particularly in patients who experience severe inflammation leading to tooth loss. By examining the biological mechanisms at play, the research seeks to identify potential new therapies for those who do not respond to standard treatments. Patients may be involved in the research to help clarify these differences and contribute to the development of targeted therapies.

Who could benefit from this research

Good fit: Ideal candidates for participation are individuals diagnosed with periodontitis, particularly those experiencing severe inflammation or tooth loss.

Not a fit: Patients with mild periodontitis or those who do not have a significant inflammatory response may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for periodontitis that are tailored based on biological sex, improving outcomes for patients suffering from this condition.

How similar studies have performed: Previous research has shown that targeting inflammasome pathways can be effective in treating other inflammatory diseases, suggesting potential for success in this area as well.

Where this research is happening

Chapel Hill, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.